Published in BMC Cancer on September 02, 2007
Involvement of TSC genes and differential expression of other members of the mTOR signaling pathway in oral squamous cell carcinoma. BMC Cancer (2008) 1.32
14-3-3ζ as a prognostic marker and therapeutic target for cancer. Expert Opin Ther Targets (2010) 1.18
Copy number gain and oncogenic activity of YWHAZ/14-3-3zeta in head and neck squamous cell carcinoma. Int J Cancer (2009) 1.01
Overexpression of YWHAZ relates to tumor cell proliferation and malignant outcome of gastric carcinoma. Br J Cancer (2013) 0.98
High-risk human papillomavirus E6 oncoproteins interact with 14-3-3ζ in a PDZ binding motif-dependent manner. J Virol (2012) 0.96
14-3-3zeta mediates resistance of diffuse large B cell lymphoma to an anthracycline-based chemotherapeutic regimen. J Biol Chem (2009) 0.91
Overexpression of prothymosin alpha predicts poor disease outcome in head and neck cancer. PLoS One (2011) 0.89
Differential tissue-specific protein markers of vaginal carcinoma. Br J Cancer (2009) 0.86
Proteomic analysis of differentially expressed proteins in peripheral cholangiocarcinoma. Cancer Microenviron (2010) 0.83
14-3-3ζ Overexpression and abnormal β-catenin expression are associated with poor differentiation and progression in stage I non-small cell lung cancer. Clin Exp Med (2010) 0.82
14-3-3ζ up-regulates hypoxia-inducible factor-1α in hepatocellular carcinoma via activation of PI3K/Akt/NF-кB signal transduction pathway. Int J Clin Exp Pathol (2015) 0.80
Investigating the clinical potential for 14-3-3 zeta protein to serve as a biomarker for epithelial ovarian cancer. J Ovarian Res (2013) 0.80
Knockdown of 14-3-3ζ enhances radiosensitivity and radio-induced apoptosis in CD133(+) liver cancer stem cells. Exp Mol Med (2014) 0.80
14-3-3ζ orchestrates mammary tumor onset and progression via miR-221-mediated cell proliferation. Cancer Res (2013) 0.80
Transcription factor KLF4 regulates microRNA-544 that targets YWHAZ in cervical cancer. Am J Cancer Res (2015) 0.79
Transcriptional regulation of YWHAZ, the gene encoding 14-3-3ζ. PLoS One (2014) 0.77
P53 suppresses expression of the 14-3-3 gamma oncogene. BMC Cancer (2011) 0.77
14-3-3ζ regulates immune response through Stat3 signaling in oral squamous cell carcinoma. Mol Cells (2014) 0.76
Proteomic and bioinformatic profile of primary human oral epithelial cells. J Proteome Res (2012) 0.75
Identification of c-MYC as a target of the APC pathway. Science (1998) 24.25
Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature (1999) 20.34
The cyclin D1 gene is a target of the beta-catenin/LEF-1 pathway. Proc Natl Acad Sci U S A (1999) 10.75
Phosphorylation of beta-catenin by AKT promotes beta-catenin transcriptional activity. J Biol Chem (2007) 4.60
The BAD protein integrates survival signaling by EGFR/MAPK and PI3K/Akt kinase pathways in PTEN-deficient tumor cells. Cancer Cell (2005) 4.48
Requirement for beta-catenin in anterior-posterior axis formation in mice. J Cell Biol (2000) 4.36
Target genes of beta-catenin-T cell-factor/lymphoid-enhancer-factor signaling in human colorectal carcinomas. Proc Natl Acad Sci U S A (1999) 4.35
14-3-3 proteins: a historic overview. Semin Cancer Biol (2006) 3.91
14-3-3-affinity purification of over 200 human phosphoproteins reveals new links to regulation of cellular metabolism, proliferation and trafficking. Biochem J (2004) 3.60
14-3-3 proteins: active cofactors in cellular regulation by serine/threonine phosphorylation. J Biol Chem (2001) 3.08
Armadillo is required for adherens junction assembly, cell polarity, and morphogenesis during Drosophila embryogenesis. J Cell Biol (1996) 2.89
14-3-3 proteins: key regulators of cell division, signalling and apoptosis. Bioessays (2001) 2.74
Profiling early head and neck cancer. Nat Rev Cancer (2005) 2.62
Cytoplasmic localization of human cdc25C during interphase requires an intact 14-3-3 binding site. Mol Cell Biol (1999) 2.21
Roles of the forkhead in rhabdomyosarcoma (FKHR) phosphorylation sites in regulating 14-3-3 binding, transactivation and nuclear targetting. Biochem J (2001) 2.19
14-3-3 proteins; bringing new definitions to scaffolding. Oncogene (2001) 2.03
Phosphatidylinositol 3-kinase signaling inhibits DAF-16 DNA binding and function via 14-3-3-dependent and 14-3-3-independent pathways. J Biol Chem (2000) 1.91
14-3-3 proteins in cell cycle regulation. Semin Cancer Biol (2006) 1.83
Surviving cell death through epidermal growth factor (EGF) signal transduction pathways: implications for cancer therapy. Cell Signal (2006) 1.82
Dynamic 14-3-3/client protein interactions integrate survival and apoptotic pathways. Semin Cancer Biol (2006) 1.78
Protein phosphatase 2A dephosphorylation of phosphoserine 112 plays the gatekeeper role for BAD-mediated apoptosis. Mol Cell Biol (2003) 1.75
Pim kinases phosphorylate multiple sites on Bad and promote 14-3-3 binding and dissociation from Bcl-XL. BMC Cell Biol (2006) 1.72
14-3-3 proteins as potential oncogenes. Semin Cancer Biol (2006) 1.72
14-3-3 Proteins--a focus on cancer and human disease. J Mol Cell Cardiol (2004) 1.67
Proteomic analysis identifies that 14-3-3zeta interacts with beta-catenin and facilitates its activation by Akt. Proc Natl Acad Sci U S A (2004) 1.66
Proteomic identification of 14-3-3zeta as a mitogen-activated protein kinase-activated protein kinase 2 substrate: role in dimer formation and ligand binding. Mol Cell Biol (2003) 1.53
The differential proteome profile of stomach cancer: identification of the biomarker candidates. Oncol Res (2004) 1.45
Significance of 14-3-3 self-dimerization for phosphorylation-dependent target binding. Mol Biol Cell (2003) 1.42
Nicotine induces multi-site phosphorylation of Bad in association with suppression of apoptosis. J Biol Chem (2004) 1.37
Identification of differentially expressed genes in oral squamous cell carcinoma. Mol Carcinog (2005) 1.36
The 14-3-3 protein FTT-2 regulates DAF-16 in Caenorhabditis elegans. Dev Biol (2006) 1.27
Phosphorylation of the histone deacetylase 7 modulates its stability and association with 14-3-3 proteins. J Biol Chem (2004) 1.23
Reduction of 14-3-3 proteins correlates with increased sensitivity to killing of human lung cancer cells by ionizing radiation. Radiat Res (2003) 1.22
Curcumin down regulates smokeless tobacco-induced NF-kappaB activation and COX-2 expression in human oral premalignant and cancer cells. Toxicology (2006) 1.18
14-3-3 proteins: regulation of endoplasmic reticulum localization and surface expression of membrane proteins. Trends Cell Biol (2006) 1.16
Efficient nuclear export of p65-IkappaBalpha complexes requires 14-3-3 proteins. J Cell Sci (2006) 1.09
Cell cycle roles for two 14-3-3 proteins during Drosophila development. J Cell Sci (2001) 1.03
Differential role of 14-3-3 family members in Xenopus development. Dev Dyn (2006) 1.00
Isoform-specific differences in rapid nucleocytoplasmic shuttling cause distinct subcellular distributions of 14-3-3 sigma and 14-3-3 zeta. J Cell Sci (2004) 1.00
Rapid identification of 14-3-3-binding proteins by protein microarray analysis. J Neurosci Methods (2005) 0.99
Alterations of rb pathway components are frequent events in patients with oral epithelial dysplasia and predict clinical outcome in patients with squamous cell carcinoma. Oncology (2005) 0.94
Expression of NF-kappaB parallels COX-2 expression in oral precancer and cancer: association with smokeless tobacco. Int J Cancer (2007) 0.93
14-3-3 regulation of cell spreading and migration requires a functional amphipathic groove. J Cell Physiol (2005) 0.88
Dynamic expression and cellular localization of the drosophila 14-3-3epsilon during embryonic development. Mech Dev (1999) 0.84
14-3-3 proteins and cancer biology. Semin Cancer Biol (2006) 0.84
Transcriptional gene expression profile of human esophageal squamous cell carcinoma. Genomics (2003) 0.83
Subcellular differences in post-translational modification of barley 14-3-3 proteins. FEBS Lett (2000) 0.78
Short course palliative radiotherapy of 20 Gy in 5 fractions for advanced and incurable head and neck cancer: AIIMS study. Radiother Oncol (2004) 2.25
Discovery and verification of head-and-neck cancer biomarkers by differential protein expression analysis using iTRAQ labeling, multidimensional liquid chromatography, and tandem mass spectrometry. Mol Cell Proteomics (2008) 1.76
Identification of differentially expressed genes in oral squamous cell carcinoma. Mol Carcinog (2005) 1.36
Expression analysis of E-cadherin, Slug and GSK3beta in invasive ductal carcinoma of breast. BMC Cancer (2009) 1.29
Promoter hypermethylation of TMS1, BRCA1, ERalpha and PRB in serum and tumor DNA of invasive ductal breast carcinoma patients. Life Sci (2007) 1.20
Curcumin down regulates smokeless tobacco-induced NF-kappaB activation and COX-2 expression in human oral premalignant and cancer cells. Toxicology (2006) 1.18
Promoter hypermethylation of p16INK4A, p14ARF, CyclinD2 and Slit2 in serum and tumor DNA from breast cancer patients. Life Sci (2007) 1.17
Oxidant stress and antioxidant status among patients with nonalcoholic fatty liver disease (NAFLD). J Clin Gastroenterol (2006) 1.16
Overview of current and future biologically based targeted therapies in head and neck squamous cell carcinoma. Head Neck Oncol (2009) 1.16
Guggulsterone, a farnesoid X receptor antagonist, inhibits constitutive and inducible STAT3 activation through induction of a protein tyrosine phosphatase SHP-1. Cancer Res (2008) 1.14
MEMD/ALCAM: a potential marker for tumor invasion and nodal metastasis in esophageal squamous cell carcinoma. Oncology (2005) 1.07
Frequent loss of Dab2 protein and infrequent promoter hypermethylation in breast cancer. Breast Cancer Res Treat (2006) 1.06
Wnt signaling pathway in invasive ductal carcinoma of the breast: relationship between beta-catenin, dishevelled and cyclin D1 expression. Oncology (2008) 1.06
Skeletal and dentoalveolar effects of Twin-block and bionator appliances in the treatment of Class II malocclusion: a comparative study. Am J Orthod Dentofacial Orthop (2006) 1.05
Nuclear S100A7 is associated with poor prognosis in head and neck cancer. PLoS One (2010) 1.04
Clinical significance of promoter hypermethylation of DNA repair genes in tumor and serum DNA in invasive ductal breast carcinoma patients. Life Sci (2010) 1.04
Clinical profile, etiology and therapeutic outcome in 324 hepatocellular carcinoma patients at a tertiary care center in India. Oncology (2009) 1.03
Heterogeneous ribonucleoprotein K is a marker of oral leukoplakia and correlates with poor prognosis of squamous cell carcinoma. Int J Cancer (2009) 1.03
Epigenetic alterations of CDH1 and APC genes: relationship with activation of Wnt/beta-catenin pathway in invasive ductal carcinoma of breast. Life Sci (2008) 1.03
Clinical significance of altered expression of β-catenin and E-cadherin in oral dysplasia and cancer: potential link with ALCAM expression. PLoS One (2013) 1.02
Angiogenesis in cutaneous melanoma: pathogenesis and clinical implications. Microsc Res Tech (2003) 1.02
Stromelysin 3, Ets-1, and vascular endothelial growth factor expression in oral precancerous and cancerous lesions: correlation with microvessel density, progression, and prognosis. Clin Cancer Res (2005) 1.01
Expression of DNA methyltransferases in breast cancer patients and to analyze the effect of natural compounds on DNA methyltransferases and associated proteins. J Breast Cancer (2013) 1.01
Prognostic significance of head-and-neck cancer biomarkers previously discovered and identified using iTRAQ-labeling and multidimensional liquid chromatography-tandem mass spectrometry. J Proteome Res (2008) 1.00
Orthodontic treatment of impacted anterior teeth due to odontomas: a report of two cases. J Clin Pediatr Dent (2004) 1.00
Weight loss during radiotherapy for head and neck malignancies: what factors impact it? Nutr Cancer (2003) 0.99
Stromelysin-2 overexpression in human esophageal squamous cell carcinoma: potential clinical implications. Cancer Detect Prev (2002) 0.99
Potent growth suppressive activity of curcumin in human breast cancer cells: Modulation of Wnt/beta-catenin signaling. Chem Biol Interact (2009) 0.99
S100A7 overexpression is a predictive marker for high risk of malignant transformation in oral dysplasia. Int J Cancer (2013) 0.99
Detection of RASSF1A and RARbeta hypermethylation in serum DNA from breast cancer patients. Epigenetics (2006) 0.97
14-3-3 zeta as novel molecular target for cancer therapy. Expert Opin Ther Targets (2012) 0.96
Treatment effects of twin-block and mandibular protraction appliance-IV in the correction of class II malocclusion. Angle Orthod (2010) 0.96
Allergic fungal sinusitis: expanding the clinicopathologic spectrum. Otolaryngol Head Neck Surg (2004) 0.96
Prognostic relevance of promoter hypermethylation of multiple genes in breast cancer patients. Cell Oncol (2009) 0.96
Stromelysin-3 expression is an early event in human oral tumorigenesis. Int J Cancer (2003) 0.95
Alterations of rb pathway components are frequent events in patients with oral epithelial dysplasia and predict clinical outcome in patients with squamous cell carcinoma. Oncology (2005) 0.94
Small interfering RNA targeting 14-3-3ζ increases efficacy of chemotherapeutic agents in head and neck cancer cells. Mol Cancer Ther (2010) 0.94
CpG hypomethylation of MDR1 gene in tumor and serum of invasive ductal breast carcinoma patients. Clin Biochem (2009) 0.94
Expression of NF-kappaB parallels COX-2 expression in oral precancer and cancer: association with smokeless tobacco. Int J Cancer (2007) 0.93
Ets-1 and VEGF expression correlates with tumor angiogenesis, lymph node metastasis, and patient survival in esophageal squamous cell carcinoma. J Cancer Res Clin Oncol (2003) 0.93
Combined evaluation of expression of telomerase, survivin, and anti-apoptotic Bcl-2 family members in relation to loss of differentiation and apoptosis in human head and neck cancers. Head Neck (2004) 0.93
Differential expression of G-protein coupled receptor 56 in human esophageal squamous cell carcinoma. Cancer Lett (2006) 0.92
Cytoplasmic accumulation of activated leukocyte cell adhesion molecule is a predictor of disease progression and reduced survival in oral cancer patients. Int J Cancer (2009) 0.92
Promoter hypermethylation in Indian primary oral squamous cell carcinoma. Int J Cancer (2010) 0.92
Preoperative diagnosis of allergic fungal sinusitis. Laryngoscope (2003) 0.91
Assessment of risk factors in laryngeal cancer in India: a case-control study. Asian Pac J Cancer Prev (2005) 0.91
Clinical significance of Maspin promoter methylation and loss of its protein expression in invasive ductal breast carcinoma: correlation with VEGF-A and MTA1 expression. Tumour Biol (2010) 0.91
Prognostic significance of nuclear pSTAT3 in oral cancer. Head Neck (2011) 0.91
Discovery of deregulation of zinc homeostasis and its associated genes in esophageal squamous cell carcinoma using cDNA microarray. Int J Cancer (2007) 0.90
Transglutaminase 2 overexpression in tumor stroma identifies invasive ductal carcinomas of breast at high risk of recurrence. PLoS One (2013) 0.90
Correlation between metabolite ratios and ADC values of prostate in men with increased PSA level. Magn Reson Imaging (2006) 0.90
Clinical significance of GPR56, transglutaminase 2, and NF-κB in esophageal squamous cell carcinoma. Cancer Invest (2010) 0.89
Orthodontic treatment of a case of Aarskog syndrome. J Clin Pediatr Dent (2003) 0.89
Demethylating agent 5-aza-2-deoxycytidine enhances susceptibility of breast cancer cells to anticancer agents. Mol Cell Biochem (2010) 0.89
Overexpression of prothymosin alpha predicts poor disease outcome in head and neck cancer. PLoS One (2011) 0.89
Solitary malignant schwannoma of the nasal cavity and paranasal sinuses: report of two rare cases. Ear Nose Throat J (2003) 0.89
An Ep-ICD based index is a marker of aggressiveness and poor prognosis in thyroid carcinoma. PLoS One (2012) 0.88
14-3-3 zeta is a molecular target in guggulsterone induced apoptosis in head and neck cancer cells. BMC Cancer (2010) 0.88
DNA methylation of circulating DNA: a marker for monitoring efficacy of neoadjuvant chemotherapy in breast cancer patients. Tumour Biol (2012) 0.88
TC21/R-Ras2 upregulation in esophageal tumorigenesis: potential diagnostic implications. Oncology (2005) 0.87
Clinical significance of TC21 overexpression in oral cancer. J Oral Pathol Med (2009) 0.87
Clinical significance of sperm protein 17 expression and immunogenicity in esophageal cancer. Int J Cancer (2007) 0.86
Immunohistochemical analysis based Ep-ICD subcellular localization index (ESLI) is a novel marker for metastatic papillary thyroid microcarcinoma. BMC Cancer (2012) 0.86
Guggulsterone (GS) inhibits smokeless tobacco and nicotine-induced NF-κB and STAT3 pathways in head and neck cancer cells. Carcinogenesis (2010) 0.86
Significance of promoter hypermethylation of p16 gene for margin assessment in carcinoma tongue. Head Neck (2009) 0.86
Orthopedic and orthodontic effects of Twin-block appliance. J Clin Pediatr Dent (2005) 0.86
Atypical goldenhar syndrome: a case report. J Clin Pediatr Dent (2006) 0.85
Secretome-based identification and characterization of potential biomarkers in thyroid cancer. J Proteome Res (2010) 0.85
Establishment and characterization of a cell line from smokeless tobacco associated oral squamous cell carcinoma. Oral Oncol (2003) 0.85
Hyoid bone position in subjects with different vertical jaw dysplasias. Angle Orthod (2011) 0.85
Orthodontic assisted tooth eruption in a dentigerous cyst: a case report. J Clin Pediatr Dent (2004) 0.84
Clinical significance of Stratifin, ERalpha and PR promoter methylation in tumor and serum DNA in Indian breast cancer patients. Clin Biochem (2009) 0.84
Clinical significance of promoter hypermethylation of ERβ and RARβ2 in tumor and serum DNA in Indian breast cancer patients. Ann Surg Oncol (2012) 0.84
MGMT expression in oral precancerous and cancerous lesions: correlation with progression, nodal metastasis and poor prognosis. Oral Oncol (2006) 0.84
Bone density and miniscrew stability in orthodontic patients. Aust Orthod J (2012) 0.84
Potential of (1)H MR spectroscopic imaging to segregate patients who are likely to show malignancy of the peripheral zone of the prostate on biopsy. J Magn Reson Imaging (2009) 0.83
Differential expression of retinoic acid receptors in normal and malignant esophageal tissues. J Exp Ther Oncol (2004) 0.83
Smokeless tobacco (khaini) extracts modulate gene expression in epithelial cell culture from an oral hyperplasia. Oral Oncol (2005) 0.83
Oncogenic osteomalacia from nasal cavity giant cell tumor. Head Neck (2010) 0.83
Transcriptional gene expression profile of human esophageal squamous cell carcinoma. Genomics (2003) 0.83
Expression analysis of maspin in invasive ductal carcinoma of breast and modulation of its expression by curcumin in breast cancer cell lines. Chem Biol Interact (2009) 0.82
Novel molecular targets of smokeless tobacco (khaini) in cell culture from oral hyperplasia. Toxicology (2006) 0.82
Sperm protein 17 is a novel marker for predicting cisplatin response in esophageal squamous cancer cell lines. Int J Cancer (2010) 0.81
Evaluation of the role of magnetization transfer imaging in prostate: a preliminary study. Magn Reson Imaging (2008) 0.81
Extrahepatic biliary atresia: Correlation of histopathology and liver function tests with surgical outcomes. J Indian Assoc Pediatr Surg (2012) 0.81
A sensitive test for the detection of specific DSB repair defects in primary cells from breast cancer specimens. Int J Cancer (2008) 0.81
siRNA-mediated downregulation of TC21 sensitizes esophageal cancer cells to cisplatin. World J Gastroenterol (2012) 0.80
Prognostic significance of stromelysin-3 and tissue inhibitor of matrix metalloproteinase-2 in esophageal cancer. Oncology (2004) 0.80
Soluble and membranous vascular endothelial growth factor receptor-2 in pregnancies complicated by pre-eclampsia. Yonsei Med J (2009) 0.80
Lactobacillus brevis CD2 lozenges reduce radiation- and chemotherapy-induced mucositis in patients with head and neck cancer: a randomized double-blind placebo-controlled study. Eur J Cancer (2011) 0.80
Loss of DLC1 is an independent prognostic factor in patients with oral squamous cell carcinoma. Mod Pathol (2011) 0.79